This inventor holds 4 USPTO granted patents and 7 published patent applications and 4 EPO patents. Top assignees: Merck Sharp & Dohme LLC, Merck Sharp + Dohme Corp.. Active years: 2014-2026.
Company Filing History:
Years Active: 2014-2026
Title: Michael Aaron Plotkin: Innovator in Bicyclic Heterocycle Compounds
Introduction
Michael Aaron Plotkin is a notable inventor based in Frenchtown, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for treating viral infections.
Latest Patents
Michael Aaron Plotkin holds a patent for "Bicyclic heterocycle compounds methods of use thereof for the treatment of herpes viruses." This invention relates to novel Bicyclic Heterocycle Compounds of Formula (I) and pharmaceutically acceptable salts thereof. The patent outlines compositions that comprise at least one Bicyclic Heterocycle Compound and methods for using these compounds to treat or prevent herpesvirus infections in patients. He has 1 patent to his name.
Career Highlights
Michael Aaron Plotkin is currently employed at Merck Sharp & Dohme LLC, a leading global healthcare company. His work focuses on innovative solutions for combating viral infections, showcasing his commitment to advancing medical science.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues, including Andrew John Cooke and Brendan M Crowley. These partnerships have contributed to the development of groundbreaking pharmaceutical solutions.
Conclusion
Michael Aaron Plotkin's work in the field of bicyclic heterocycle compounds exemplifies the innovative spirit of modern pharmaceutical research. His contributions are vital in the ongoing fight against viral infections, particularly herpes viruses.